MYRIAD GENETICS, INC. Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
MYRIAD GENETICS, INC. (MYGN) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $200.00 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2013-11-12
- MYRIAD GENETICS, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-09-30 was $500.00M, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2011-12-31 was $0.00.
- MYRIAD GENETICS, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2011-09-30 was $500.00M.
- MYRIAD GENETICS, INC. stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2013 was $700.00M.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 0 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 2 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 5 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 8 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $200.00M 10-Q · filed 2013-11-12 | ||||||||
| 2013-06-30 | $700.00M 10-K · filed 2013-08-14 | ||||||||
| 2013-02-28 | $200.00M 10-K · filed 2013-08-14 | ||||||||
| 2012-09-30 | $200.00M 10-Q · filed 2012-11-09 | $500.00M 10-Q · filed 2012-11-09 | |||||||
| 2012-06-30 | $500.00M 10-K · filed 2012-08-15 | ||||||||
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | $0.00 derived: sum of 2 quarters · filed 2012-05-02 | $200.00M 10-Q · filed 2012-05-02 | $500.00M 10-Q · filed 2012-05-02 | |||||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | $200.00M 10-Q · filed 2012-02-01 | $500.00M 10-Q · filed 2012-02-01 | ||||||
| 2011-09-30 | $500.00M 10-Q · filed 2011-11-02 | ||||||||
| 2011-08-31 | $200.00M 10-K · filed 2013-08-14 | ||||||||
| 2011-08-16 | $200.00M 10-Q · filed 2011-11-02 | ||||||||
| 2011-03-31 | $100.00M 10-K · filed 2013-08-14 | $100.00M 10-Q · filed 2012-11-09 | |||||||
| 2010-08-31 | $100.00M 10-K · filed 2013-08-14 | ||||||||
| 2010-05-31 | $100.00M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |